Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NESP Dose-Finding for Anemia in Solid Tumors
NCT00540384Phase 2Completed
- Sponsor
- Amgen
- Start
- Jul 1999
- Primary completion
- Mar 2002
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 2 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Jul 1999; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00540384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540384.